Brief: Aditxt Says Will Provide $1.5 Mln Of Financing By Sept 30, Additional $1.5 Mln By Oct 31
Sept 9 (Reuters) - Aditxt Inc ADTX.O :
* ADITXT AND EVOFEM SIGN SECOND AMENDMENT TO AMENDED AND
RESTATED
MERGER AGREEMENT, TARGET CLOSING OF ACQUISITION IN FOURTH
QUARTER OF 2024
* ADITXT INC - WILL PROVIDE $1.5 MILLION OF FINANCING BY
SEPT 30,
AND ADDITIONAL $1.5 MILLION BY OCTOBER 31
* ADITXT- EXTENDED DATES BY WHICH CO COMPLETES REMAINING $3
MILLION FUNDING TO EVOFEM THROUGH PURCHASE OF 3,000 SHARES OF
EVOFEM'S F-1 PREFERRED STOCK
Source text for Eikon: ID:nBw5DJ7Qta
Further company coverage: ADTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evofem Biosciences
See all newsBrief: Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy
Brief: HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition Of Evofem Notes
Evofem Biosciences Q1 sales edge up on higher pricing
Evofem Biosciences Q3 net sales rise
Brief: Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting